MHRA recalls batches of Epilim 500mg gastro-resistant tablets

The Medicines and Healthcare products Regulatory Agency has told healthcare professionals to immediately stop supplying batches of Epilim 500mg gastro-resistant tablets.

The medicines regular’s instruction follows a recall of the product by manufacturer Sanofi due to what the PSNC reported was “out of specification results for disintegration test during routine stability testing.”

The MHRA also said affected stock with the batch numbers R0601, R0602 and R0603 should be quarantined and returned to suppliers.

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.